Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma
The proposed mechanisms of action of lenalidomide in multiple myeloma... | Download Scientific Diagram
Frontiers | Thalidomide-Revisited: Are COVID-19 Patients Going to Be the Latest Victims of Yet Another Theoretical Drug-Repurposing? | Immunology
Therapeutic Potential of Thalidomide and Its Analogues in the Treatment of Cancer | Anticancer Research
The molecular mechanism of thalidomide analogs in hematologic malignancies | SpringerLink
Immunomodulatory imide drug - Wikipedia
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma | Leukemia
Multiple myeloma - The Lancet
Thalidomide in multiple myeloma - ScienceDirect
Thalidomide for the treatment of multiple myeloma - Hattori - 2004 - Congenital Anomalies - Wiley Online Library
Lenalidomide in the Treatment of Multiple Myeloma
Renal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma | American Society of Nephrology
Drug Insight: thalidomide as a treatment for multiple myeloma | Semantic Scholar
Thalidomide and its analogues: A review of the potential for immunomodulation of fibrosis diseases and opthalmopathy (Review)
Thalidomide (Contergan) - Annotated Collection of Links
Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma - touchONCOLOGY
Lenalidomide and Thalidomide: Mechanisms of Action—Similarities and Differences - ScienceDirect
POMALYST® (pomalidomide) Mechanism of Action
Thalidomide: Unlocking a dark past | eLife
Pharmaceuticals | Free Full-Text | Molecular Mechanisms of the Teratogenic Effects of Thalidomide
Recent advances in the molecular mechanism of thalidomide teratogenicity - ScienceDirect
Thalidomide in multiple myeloma in the elderly | Aging Health
Mechanism of thalidomide on MM cells. Thalidomide arrests MM cells in... | Download Scientific Diagram
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma | NEJM
References in Thalidomide for Patients With Relapsed Multiple Myeloma After High-Dose Chemotherapy and Stem Cell Transplantation: Results of an Open-Label Multicenter Phase 2 Study of Efficacy, Toxicity, and Biological Activity - Mayo
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma | Leukemia
